Standardizing potency assays across vaccine platforms
Detecting low levels of process-related impurities
Developing specific assays for novel modalities (e.g., mRNA physicochemical characterization)
Methods for quantitative detection of residual host cell DNA and target gene copy number.
Highly pure peptides for use as ELISA standards to measure antigen-specific antibodies.
Offering services in sequence design & optimization, gene synthesis, and plasmid extraction to support the research and validation of mRNA vaccines/therapies.
Reagents are produced with assay validation and regulatory compliance in mind.
Tools support mRNA, DNA, viral vector, and protein subunit vaccines.
Deep understanding of vaccine analytics and regulatory requirements.
Consistent supply of critical reagents for long-term development programs.
Stay updated with the latest industry news and expert insights.
Subscribe now to receive:
● Industry updates
● Exclusive expert insights and analysis
Enter your email to stay ahead!
